We are live on
!
Find out more
Assenagon Asset Management Portfolio holdings
AUM
$80.2B
1-Year Est. Return
50.56%
This Fund
S&P 500
This Quarter
Est. Return
-2.31%
1 Year Est. Return
+50.56%
3 Year Est. Return
+139.16%
5 Year Est. Return
+175.94%
10 Year Est. Return
–
AUM
$65.9B
AUM Growth
-$6.77B
(-9.3%)
Cap. Flow
-$45M
Cap. Flow
% of AUM
-0.07%
Top 10 Holdings %
Top 10 Hldgs %
38.99%
Holding
1,238
New
95
Increased
438
Reduced
526
Closed
143
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.23B |
| 2 |
Microsoft
MSFT
|
+$1.21B |
| 3 |
Tesla
TSLA
|
+$712M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$704M |
| 5 |
Chevron
CVX
|
+$535M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$612M |
| 2 |
Apple
AAPL
|
+$601M |
| 3 |
Procter & Gamble
PG
|
+$518M |
| 4 |
Texas Instruments
TXN
|
+$490M |
| 5 |
Pinduoduo
PDD
|
+$477M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.83% |
| 2 | Consumer Discretionary | 15.45% |
| 3 | Healthcare | 12.45% |
| 4 | Communication Services | 9.01% |
| 5 | Financials | 6.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Spyre Therapeutics
SYRE
$8.25B
| $941K | ﹤0.01% |
18,647
-3,489
| -16% | -$132K |
|
902
SBA Communications
SBAC
$19.8B
| $940K | ﹤0.01% |
5,462
+248
| +5% | +$46.5K |
|
903
Astronics
ATRO
$3.35B
| $937K | ﹤0.01% |
16,846
-76,504
| -82% | -$4.62M |
|
904
Royalty Pharma
RPRX
$27.6B
| $933K | ﹤0.01% |
19,442
+669
| +4% | +$29.3K |
|
905
Bloom Energy
BE
$64.2B
| $929K | ﹤0.01% |
6,857
+716
| +12% | +$105K |
|
906
Bridgewater Bancshares
BWB
$594M
| $919K | ﹤0.01% |
51,922
-19,260
| -27% | -$353K |
|
907
EnerSys
ENS
$6.89B
| $913K | ﹤0.01% |
+5,257
| New | +$890K |
|
908
Coherent
COHR
$57.8B
| $902K | ﹤0.01% |
+3,786
| New | +$867K |
|
909
Dollar General
DG
$27.8B
| $896K | ﹤0.01% |
7,545
-53
| -0.7% | -$7.56K |
|
910
Elbit Systems
ESLT
$33.7B
| $895K | ﹤0.01% |
1,072
-363
| -25% | -$280K |
|
911
Becton Dickinson
BDX
$51.2B
| $891K | ﹤0.01% |
5,670
-874
| -13% | -$160K |
|
912
International Seaways
INSW
$4.92B
| $880K | ﹤0.01% |
12,080
-6,665
| -36% | -$426K |
|
913
Ventas
VTR
$47.6B
| $878K | ﹤0.01% |
10,731
+649
| +6% | +$53.1K |
|
914
Veracyte
VCYT
$3.64B
| $871K | ﹤0.01% |
27,038
| – | – |
|
915
Fortrea Holdings
FTRE
$1.79B
| $855K | ﹤0.01% |
90,780
-24,999
| -22% | -$321K |
|
916
Public Storage
PSA
$58.1B
| $852K | ﹤0.01% |
3,144
| – | – |
|
917
Hain Celestial
HAIN
$64.1M
| $850K | ﹤0.01% |
1,218,733
+900,831
| +283% | +$836K |
|
918
JELD-WEN Holding
JELD
$189M
| $847K | ﹤0.01% |
682,899
-322,385
| -32% | -$705K |
|
919
GE HealthCare
GEHC
$32.7B
| $843K | ﹤0.01% |
11,846
-667
| -5% | -$52.6K |
|
920
Green Brick Partners
GRBK
$3.13B
| $840K | ﹤0.01% |
13,036
| – | – |
|
|
MICC
921
The Magnum Ice Cream Company N.V.
MICC
$12.3B
| $840K | ﹤0.01% |
57,368
+37,040
| +182% | +$600K |
|
922
Rivian
RIVN
$24.3B
| $837K | ﹤0.01% |
55,624
+2,531
| +5% | +$40.5K |
|
923
Brown-Forman Class B
BF.B
$12.5B
| $833K | ﹤0.01% |
31,508
-85,662
| -73% | -$2.3M |
|
924
Avantor
AVTR
$9.88B
| $832K | ﹤0.01% |
106,070
-3,514,385
| -97% | -$34.6M |
|
925
Encore Capital Group
ECPG
$2.16B
| $819K | ﹤0.01% |
11,676
-4,822
| -29% | -$296K |
|
Similar funds
CBU
Assenagon Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, Assenagon Asset Management held 1,238 positions worth $65.9B, down 9.3% from $72.6B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Assenagon Asset Management's Q1 2026 filing shows 95 new, 438 increased, 526 reduced and 143 closed positions. Its largest new stake was Webster Financial: 1,581,021 shares worth $110M. The largest sale was Costco, an estimated $612M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Assenagon Asset Management's largest Q1 2026 buy was Webster Financial: 1,581,021 shares worth $110M.
- Assenagon Asset Management added most to Eli Lilly in Q1 2026, an estimated $1.23B increase.
- Assenagon Asset Management's biggest Q1 2026 reduction was Costco, cutting an estimated $612M.
- Assenagon Asset Management fully exited Praxis Precision Medicines in Q1 2026, selling an estimated $120M.
- Assenagon Asset Management's ten largest holdings make up 39% of its $65.9B portfolio in Q1 2026.
- Assenagon Asset Management opened 95 new positions and closed 143 in Q1 2026.
- Assenagon Asset Management's portfolio value fell 9.3% quarter-over-quarter to $65.9B.
Based on Assenagon Asset Management's 13F filing for Q1 2026, filed 20 Apr 2026.